Motion to Concur in the House Amendment to Accompany S. 3187; A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
On the Motion
06/26/2012
Senate Roll Call No. 168
112nd Congress, 2nd Session
By 92 yeas to 4 nays (Vote No. 168), Senate agreed to the motion to concur in the amendment of the House of Representatives to S. 3187, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars.